- Home
- ALB vs BMRN Comparison
ALB vs BMRN Comparison
Compare ALB & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALB
- BMRN
- Stock Information
- Founded
- ALB 1994
- BMRN 1996
- Country
- ALB United States
- BMRN United States
- Employees
- ALB N/A
- BMRN N/A
- Industry
- ALB Major Chemicals
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ALB Industrials
- BMRN Health Care
- Exchange
- ALB Nasdaq
- BMRN Nasdaq
- Market Cap
- ALB 11.7B
- BMRN 12.1B
- IPO Year
- ALB 1994
- BMRN 1999
- Fundamental
- Price
- ALB $57.93
- BMRN $58.86
- Analyst Decision
- ALB Hold
- BMRN Buy
- Analyst Count
- ALB 20
- BMRN 22
- Target Price
- ALB $89.25
- BMRN $93.43
- AVG Volume (30 Days)
- ALB 3.3M
- BMRN 1.6M
- Earning Date
- ALB 04-30-2025
- BMRN 05-01-2025
- Dividend Yield
- ALB 2.81%
- BMRN N/A
- EPS Growth
- ALB N/A
- BMRN 152.82
- EPS
- ALB N/A
- BMRN 2.71
- Revenue
- ALB $5,093,671,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- ALB N/A
- BMRN $12.27
- Revenue Next Year
- ALB $12.82
- BMRN $9.86
- P/E Ratio
- ALB N/A
- BMRN $21.79
- Revenue Growth
- ALB N/A
- BMRN 19.36
- 52 Week Low
- ALB $49.43
- BMRN $52.93
- 52 Week High
- ALB $137.50
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- ALB 44.81
- BMRN 37.63
- Support Level
- ALB $55.64
- BMRN $58.74
- Resistance Level
- ALB $58.75
- BMRN $61.26
- Average True Range (ATR)
- ALB 2.65
- BMRN 1.98
- MACD
- ALB 0.75
- BMRN -0.03
- Stochastic Oscillator
- ALB 45.36
- BMRN 1.80
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.